AGP Picks
View all

Journal of Business News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Journal of Business News.

Press releases published on November 8, 2026

The Valley Law Group Relocates Phoenix Office to Grand Central Tower to Support Continued Growth
Long Island Cafe and Seven Sponsors Aim to Feed 2,500 Veterans and Families at Biggest Veterans Day Breakfast Yet
Frozen-Pipe Claims Now Top $30,000. Here's Why Puget Sound Pipes Burst Where There's No Ice
Black Friday Delivery in NYC: Xentra Transport Same-Day Courier Now Available for Businesses Seeking Holiday Pickups
Backyard Taco Honors Veterans Day With Free Meals Up to $15 on November 11
Acclaimed Immigration Attorney Tahmina Watson Debuts Bird Photography Exhibition
One Practice, the Full Surgical Ladder: Dental Implants, Zygomatic Implants, Sinus Lifts and More In-House
Free Medicare Price Comparison Tool Launches With No Contact Information Required
Theo Jaeger's Debut Fantasy Novel 'Darkness and Light' Explores Courage, Destiny, and the Fight for Freedom
2026 Census Results: Censible to Publish Data for Every Australian Suburb
From Dubai to Michigan: Watchmaker Suleman Qureshi's International Career
TanYah Global Releases ‘The Gully Side Book Series,’ Bringing Jamaican Culture and Community Stories to Fiction
Six AGIBOT G2 Robots Complete 1,730 Tasks in 24-Hour Shanghai Convenience Store Trial
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Tenax Therapeutics, Inc. (NASDAQ: TENX) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Gildan Activewear Inc. (GIL) Investor Alert: GIL Stock Drops Further Amid Poor Q3 Earnings; December 14, 2026 Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026
CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune Diseases
BETR DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Better Home & Finance Holding Company Investors to Secure Counsel Before Important November 20 Deadline in Securities Class Action - BETR
SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against D-Wave Quantum Inc. (NASDAQ: QBTS) — Investors Who Suffered Losses Are Encouraged to Contact the Firm
Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026 Featuring Immunomodulator-Free Durability and Favorable Benefit-Risk Profile Across Autoimmune Diseases

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Journal of Business News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.